Literature DB >> 15308273

Pathogens resistant to antimicrobial agents: epidemiology, molecular mechanisms, and clinical management.

Keith S Kaye1, John J Engemann, Henry S Fraimow, Elias Abrutyn.   

Abstract

Resistance to antimicrobial drugs is increasing at an alarming rate among both gram-positive and gram-negative bacteria. Traditionally, bacteria resistant to multiple antimicrobial agents have been restricted to the nosocomial environment. A disturbing trend has been the recent emergence and spread of resistant pathogens and resistance traits in nursing homes, the community, as well as in hospitals. This article reviews the epidemiology, molecular mechanisms of resistance, and treatment options for pathogens resistant to antimicrobial drugs.

Mesh：

Substances：

Year:  2004        PMID： 15308273     DOI： 10.1016/j.idc.2004.04.003

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN： 0891-5520            Impact factor:   5.982


  18 in total

Review 1.  Antimicrobial resistance: a global multifaceted phenomenon.

Authors:  Francesca Prestinaci; Patrizio Pezzotti; Annalisa Pantosti
Journal:  Pathog Glob Health       Date:  2015-09-07       Impact factor: 2.894

2.  Meningitis due to vancomycin-resistant Enterococcus faecium successfully treated with combined intravenous and intraventricular chloramphenicol.

Authors:  Pablo Gustavo Scapellato; Cecilia Ormazabal; José Luis Scapellato; Edgardo Gabriel Bottaro
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

3.  Extended-spectrum β-lactamase (ESBL) in Omani Children: Study of prevalence, risk factors and clinical outcomes at Sultan Qaboos University Hospital, Sultanate of Oman.

Authors:  Zakariya Al Muharrmi; Akbar M Rafay; Abdullah Balkhair; Salem Al-Tamemi; Ali Al Mawali; Hilal Al Sadiri
Journal:  Sultan Qaboos Univ Med J       Date:  2008-07

4.  Clinical impact of extended-spectrum β-lactamase-producing Enterobacteriaceae in patients with biliary tract infection.

Authors:  Hong Joo Kim; Jung Ho Park; Dong Il Park; Yong Kyun Cho; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim
Journal:  Dig Dis Sci       Date:  2012-09-14       Impact factor: 3.199

Review 5.  [Complicated intra-abdominal infections: pathogens, resistance. Recommendations of the Infectliga on antbiotic therapy].

Authors:  K-F Bodmann
Journal:  Chirurg       Date:  2010-01       Impact factor: 0.955

6.  Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.

Authors:  Teena Chopra; Dror Marchaim; Jennifer Veltman; Paul Johnson; Jing J Zhao; Ryan Tansek; Dania Hatahet; Khawar Chaudhry; Jason M Pogue; Hiro Rahbar; Ting-Yi Chen; Thientu Truong; Victor Rodriguez; Joseph Ellsworth; Luigino Bernabela; Ashish Bhargava; Adnan Yousuf; George Alangaden; Keith S Kaye
Journal:  Antimicrob Agents Chemother       Date:  2012-04-30       Impact factor: 5.191

7.  Methicillin-resistant Staphylococcus aureus infections of the eye and orbit (an American Ophthalmological Society thesis).

Authors:  Preston Howard Blomquist
Journal:  Trans Am Ophthalmol Soc       Date:  2006

8.  Successive emergence of extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacter aerogenes isolates in a university hospital.

Authors:  M Biendo; B Canarelli; D Thomas; F Rousseau; F Hamdad; C Adjide; G Laurans; F Eb
Journal:  J Clin Microbiol       Date:  2008-01-30       Impact factor: 5.948

9.  Addition of rifampin to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus.

Authors:  David J Riedel; Elizabeth Weekes; Graeme N Forrest
Journal:  Antimicrob Agents Chemother       Date:  2008-05-12       Impact factor: 5.191

10.  Ciprofloxacin-Loaded Keratin Hydrogels Prevent Pseudomonas aeruginosa Infection and Support Healing in a Porcine Full-Thickness Excisional Wound.

Authors:  Daniel C Roy; Seth Tomblyn; David M Burmeister; Nicole L Wrice; Sandra C Becerra; Luke R Burnett; Justin M Saul; Robert J Christy
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-08-01       Impact factor: 4.730
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.